Sars Cov 1 Antibody Test Results

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525

Human IgG antibody Laboratories manufactures the sars cov 1 antibody test results reagents distributed by Genprice. The Sars Cov 1 Antibody Test Results reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars products are available in stock. Specificity: Sars Category: Cov Group: 1 Antibody

Human IgG Quick test strip

10Tests
EUR 260

Human IgG Quick test strip

5x10Tests
EUR 1180

COX (Coxsackievirus Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of COX (Coxsackievirus Antibody IgG)

Monoclonal antibody to human IgG for rapid test

1mg
EUR 480

Monoclonal antibody to human IgG for rapid test

2mg
EUR 700

Monoclonal antibody to human IgG for rapid test

5mg
EUR 1505

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

100 µl
EUR 650

1 Antibody information

TruStrip RDT Sulfonamides residues (SAs) rapid test strips, results is 2-10 mins, 50 strips/pk

DE-100090-RDT 1 pk
EUR 781.2

TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk

DE-100260-RDT 1 pk Ask for price

TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk

RV-501200-RDT 1 pk Ask for price

TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk

AE-320880-RDT-25 1 pk
EUR 351.6

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-100l 100 µl
EUR 650

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-1ml 1 ml
EUR 10500

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-200l 200 µl
EUR 2100

SARS-CoV-2 Neutralization Antibody Rapid Test Kit

abx092242-100l 100 µl
EUR 1925

SARS-CoV-2 Neutralization Antibody Rapid Test Kit

abx092242-1ml 1 ml
EUR 22500

SARS-CoV-2 Neutralization Antibody Rapid Test Kit

abx092242-200l 200 µl
EUR 6600

SARS-CoV-2 Antigen Rapid Test

INCP-502H 25 Tests
EUR 8.75

Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores

BR20838 row: 13; column: 16; cores: 208; cases: 118
EUR 474
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case

anti- SARS antibody

FNab07609 100µg
EUR 658.5
Description: Antibody raised against SARS

Anti SARS-Cov-2 Spike Pab

112039 100 µg Ask for price

Anti SARS-Cov-2 Spike Mab

112056 100 µg Ask for price

Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

BR20824 row: 13; column: 16; cores: 208; cases: 104
EUR 474
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case

SARS-CoV-2 Ag Rapid Test

HSGIA2200A1COV 20 Tests/Kit Ask for price
Description: The SARS-CoV-2 Ag Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in nasal swab specimens from individualswith suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests. Results are for the detection of SARS-CoV-2 Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The SARS-CoV-2 Ag Rapid Test is intended for use by self-testing personnel.